Pharmacology

Results from the STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH) double-blind, randomized, multicenter trial from 2014 to 2020 found that in…

Recently, Pfizer and BioNTech released promising preliminary results of their clinical Phase III trials with 40,000 participants for their RNA vaccine candidate. This report suggests 90% efficacy for…

The COVID-19 pandemic has sent both political parties rushing to wrap themselves in the flag of science - even those voters who were historically more inclined to oppose vaccines and medicine and…

After clinical trials showed the safety and efficacy of Veklury (remdesivir) in adult and pediatric patients 12 years of age and older, the U.S. Food and Drug Administration has approved the…

Cannabidiol, a chemical found in marijuana plants, is enjoying a wave of financial success due to strange prescriptions for "medical" marijuana, which ended up overwhelmingly being obtained for…

The SARS-CoV-2 virus, the 2019 form of coronavirus that has caused the COVID-19 pandemic, has led to a rush of studies searching for a vaccine to prevent infection and testing existing drugs to see…

The 'teach to the protocol' environment created by government and insurance companies has removed much of the critical thinking in modern medicine, and a new paper suggests even more regulations are…

Some menopausal women experience night sweats and hot flashes. Hormone replacement therapy is the standard of care for menopausal patients, but not all women are good candidates for it and then some…

A new paper claims that treatment with the antiviral drug remdesivir does not speed recovery from COVID-19 versus placebo in hospitalized patients who are critically ill. But this needs to be…

Patients with hypertension, heart failure, and chronic kidney disease are at increased risk of severe coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus that originated in Wuhan,…